The global rise in obesity and type 2 diabetes is fueling an epidemic of MASLD and MASH, now recognized as the leading cause ...

With the rising epidemic of obesity, metabolic syndrome, and type 2 diabetes mellitus in China, metabolic ...

Health department starting fatty liver clinics in district hospitals for early diagnosis and treatment of liver diseases.

In patients with metabolic dysfunction-associated steatotic liver disease, there is increased risk for heart failure with preserved ejection fraction.

Discover how semaglutide aids weight loss in individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD ...

Researchers from Georgia Southern University's Jiann-Ping Hsu College of Public Health have discovered a positive trend in ...

Patients with celiac disease have double the incidence rate of chronic liver disease compared with those without this ...

Patients with type 1 diabetes comorbid with metabolic dysfunction-associated steatotic liver disease had a low prevalence of advanced liver fibrosis.

A 96-week clinical trial found that 300 mg of Vitamin E significantly improved liver histology and reduced inflammation in ...

"The combination of MASLD, sarcopenia, and advanced fibrosis further worsened outcomes (HR 3.41). Additionally, metabolic dysfunction-associated alcohol-related liver disease (MetALD) and other ...

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that ...

Updated guidance on preventing atherosclerotic cardiovascular disease in people with dyslipidemia includes changes reflecting ...